# Tarsus Pharmaceuticals, Inc. (TARS) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Tarsus Pharmaceuticals, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/TARS/mda/fy2025/): filed 2026-02-23; accession 0001819790-26-000019 (https://www.sec.gov/Archives/edgar/data/1819790/000181979026000019/tars-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/TARS/mda/fy2024/): filed 2025-02-25; accession 0001819790-25-000011 (https://www.sec.gov/Archives/edgar/data/1819790/000181979025000011/tars-20241231.htm)
- [FY 2023 MD&A](/company/TARS/mda/fy2023/): filed 2024-02-27; accession 0001819790-24-000018 (https://www.sec.gov/Archives/edgar/data/1819790/000181979024000018/tars-20231231.htm)
- [FY 2022 MD&A](/company/TARS/mda/fy2022/): filed 2023-03-17; accession 0001819790-23-000007 (https://www.sec.gov/Archives/edgar/data/1819790/000181979023000007/tars-20221231.htm)
- [FY 2021 MD&A](/company/TARS/mda/fy2021/): filed 2022-03-14; accession 0001819790-22-000010 (https://www.sec.gov/Archives/edgar/data/1819790/000181979022000010/tars-20211231.htm)

Back to /company/TARS/